Patents by Inventor Per Holse Mygind

Per Holse Mygind has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antimicrobial Peptide Variants and Polynucleotides Encoding Same
    Publication number: 20160158317
    Abstract: The present invention relates to variants of a parent antimicrobial peptide. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: February 13, 2016
    Publication date: June 9, 2016
    Applicant: Adenium Biotech A/S
    Inventors: Hans-Henrik Kristensen Hoegenhaug, Per Holse Mygind, Thomas Kruse, Dorotea Raventos Segura, Dorthe Hoj Sandvang, Soren Neve
  • Treatment of inflammatory bowel diseases with mammal beta defensins
    Patent number: 9279010
    Abstract: The present invention relates to treatment of inflammatory bowel diseases with mammal beta defensins.
    Type: Grant
    Filed: January 30, 2014
    Date of Patent: March 8, 2016
    Assignee: Defensin Therapeutics ApS
    Inventors: Tanja Maria Rosenkilde Kjaer, Thomas Kruse, Per Holse Mygind, Karoline Sidelmann Brinch, Soeren Kjaerulff, Birgitte Andersen
  • Antimicrobial Peptide Variants and Polynucleotides Encoding Same
    Publication number: 20150031601
    Abstract: The present invention relates to variants of a parent antimicrobial peptide. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: August 11, 2014
    Publication date: January 29, 2015
    Applicant: ADDENIUM BIOTECH APS
    Inventors: Hans-Henrik Kristensen Hoegenhaug, Per Holse Mygind, Thomas Kruse, Dorotea Raventos Segura, Dorthe Hoj Sandvang, Soren Neve
  • Antimicrobial peptide variants and polynucleotides encoding same
    Patent number: 8835604
    Abstract: The present invention relates to variants of a parent antimicrobial peptide. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: June 2, 2011
    Date of Patent: September 16, 2014
    Assignee: Adenium Biotech Aos
    Inventors: Hans-Henrik Kristensen Hoegenhaug, Per Holse Mygind, Thomas Kruse, Dorotea Raventos Segura, Dorthe Hoj Sandvang, Soren Neve
  • Treatment of inflammatory bowel diseases with mammal beta defensins
    Patent number: 8802621
    Abstract: The present invention relates to treatment of inflammatory bowel diseases with mammal beta defensins.
    Type: Grant
    Filed: June 13, 2011
    Date of Patent: August 12, 2014
    Assignee: Defensin Therapeutics ApS
    Inventors: Tanja Maria Rosenkilde Kjaer, Thomas Kruse, Per Holse Mygind, Karoline Sidelmann Brinch, Soeren Kjaerulff, Birgitte Andersen
  • Treatment of Inflammatory Bowel Diseases with Mammal Beta Defensins
    Publication number: 20140135258
    Abstract: The present invention relates to treatment of inflammatory bowel diseases with mammal beta defensins.
    Type: Application
    Filed: January 30, 2014
    Publication date: May 15, 2014
    Applicant: Defensin Therapeutics ApS
    Inventors: Tanja Maria Rosenkilde Kjaer, Thomas Kruse, Per Holse Mygind, Karoline Sidelmann Brinch, Soeren Kjaerulff, Birgitte Andersen
  • Treatment of Inflammatory Bowel Diseases With Mammal Beta Defensins
    Publication number: 20120309678
    Abstract: The present invention relates to treatment of inflammatory bowel diseases with mammal beta defensins.
    Type: Application
    Filed: July 9, 2012
    Publication date: December 6, 2012
    Applicant: Novozymes Adenium Biotech A/S
    Inventors: Tanja Maria Rosenkilde Kjaer, Thomas Kruse, Per Holse Mygind, Karoline Sidelmann Brinch, Soeren Kjaerulff, Birgitte Andersen
  • Treatment of Rheumatoid Arthritis With Mammal Beta Defensins
    Publication number: 20120309686
    Abstract: The present invention relates to treatment of rheumatoid arthritis with mammal beta defensins.
    Type: Application
    Filed: July 9, 2012
    Publication date: December 6, 2012
    Applicant: Novozymes Adenium Biotech A/S
    Inventors: Tanja Maria Rosenkilde Kjaer, Thomas Kruse, Per Holse Mygind, Karoline Sidelmann Brinch, Soeren Kjaerulff, Birgitte Andersen
  • Treatment of rheumatoid arthritis with mammal beta defensins
    Patent number: 8232248
    Abstract: The present invention relates to treatment of rheumatoid arthritis with mammal beta defensins.
    Type: Grant
    Filed: July 17, 2009
    Date of Patent: July 31, 2012
    Assignee: Novozymes Adenium Biotech A/S
    Inventors: Tanja Maria Rosenkilde Kjaer, Thomas Kruse, Per Holse Mygind, Karoline Sidelmann Brinch, Soeren Kjaerulff, Birgitte Andersen
  • Treatment of inflammatory bowel diseases with mammal beta defensins
    Patent number: 8232242
    Abstract: The present invention relates to treatment of inflammatory bowel diseases with mammal beta defensins.
    Type: Grant
    Filed: July 17, 2009
    Date of Patent: July 31, 2012
    Assignee: Novozymes Adenium Biotech A/S
    Inventors: Tanja Maria Rosenkilde Kjaer, Thomas Kruse, Per Holse Mygind, Karoline Sidelmann Brinch, Soeren Kjaerulff, Birgitte Andersen
  • Polypeptides having antimicrobial activity and polynucleotides encoding same
    Patent number: 8192925
    Abstract: The present invention relates to isolated polypeptides having antimicrobial activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: May 13, 2008
    Date of Patent: June 5, 2012
    Assignee: Novozymes Adenium Biotech A/S
    Inventors: Per Holse Mygind, Mogens Trier Hansen, Marianne Vind Sorensen, Dorthe Sandvang
  • POLYPEPTIDES HAVING ANTIMICROBIAL ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME
    Publication number: 20120004159
    Abstract: The present invention relates to isolated polypeptides having antimicrobial activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: May 13, 2008
    Publication date: January 5, 2012
    Applicant: Novozymes A/S
    Inventors: Per Holse Mygind, Mogens Trier Hansen, Marianne Vind Soerensen, Dorthe Sandvang
  • Antimicrobial polypeptides
    Patent number: 8080390
    Abstract: The present invention relates to polypeptides having antimicrobial activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: January 19, 2009
    Date of Patent: December 20, 2011
    Assignee: Novozymes Adenium Biotech A/S
    Inventors: Hans-Henrik Kristensen Hogenhaug, Per Holse Mygind, Dorotea Raventos Segura, Olivier Taboureau, Carsten Peter Sonksen
  • ANTIMICROBIAL PEPTIDE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME
    Publication number: 20110306750
    Abstract: The present invention relates to variants of a parent antimicrobial peptide. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: June 2, 2011
    Publication date: December 15, 2011
    Applicant: Novozymes A/S
    Inventors: Hans-Henrik Kristensen Hoegenhaug, Per Holse Mygind, Thomas Kruse, Dorotea Raventos Segura, Dorthe Hoj Sandvang, Soren Neve
  • TREATMENT OF INFLAMMATORY BOWEL DISEASES WITH MAMMAL BETA DEFENSINS
    Publication number: 20110251139
    Abstract: The present invention relates to treatment of inflammatory bowel diseases with mammal beta defensins.
    Type: Application
    Filed: June 13, 2011
    Publication date: October 13, 2011
    Applicant: NOVOZYMES A/S
    Inventors: TANJA MARIA ROSENKILDE KJAER, THOMAS KRUSE, PER HOLSE MYGIND, KAROLINE SIDELMANN BRINCH, SOEREN KJAERULFF, BIRGITTE ANDERSEN
  • Antimicrobial polypeptides from
    Patent number: 7972814
    Abstract: The present invention relates to polypeptides having antimicrobial activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: November 20, 2002
    Date of Patent: July 5, 2011
    Inventors: Kirk Matthew Schnorr, Mogens Trier Hansen, Per Holse Mygind, Dorotea Raventos Segura, Hans-Henrik Hogenhaug Kristensen
  • Polypeptides having Antimicrobial Activity and Polynucleotides Encoding Same
    Publication number: 20110160122
    Abstract: The present invention relates to isolated polypeptides having antimicrobial activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: January 5, 2011
    Publication date: June 30, 2011
    Applicant: Novozymes Adenium Biotech A/S
    Inventors: Dorotea Raventos Segura, Per Holse Mygind, Mogens Trier Hansen, Marianne Vind Soerensen, Dorthe Sandvang
  • Recombinant production of antimicrobial peptides
    Patent number: 7935501
    Abstract: The invention relates to the use of co-expression of an antimicrobial agent and an enzyme, with a view to improving yield and/or overall production economy. Examples of antimicrobial agents are antimicrobial peptides such as lactoferricins and antimicrobial enzymes such as lysozyme and glucose oxidase, and examples of enzymes are endoglucanase, xylanase, phytase, protease, galactanase, mannanase, dextranase, alpha-galactosidase, pectate lyase, alpha-amylase and glucoamylase. A fusion product comprising the antimicrobial agent and the enzyme and a cleavable linker is novel, and can be used in animal feed and animal feed additives. The invention also describes the use of a protection domain wherein at least 50% of the amino acid residues comprised in the peptide protection domain are D (Asp) and/or E (Glu). The protection or quenching domain serves to temporarily and reversibly inactivate the antimicrobial peptide during the expression.
    Type: Grant
    Filed: September 13, 2004
    Date of Patent: May 3, 2011
    Assignee: Novozymes Pharma Biotec A/S
    Inventors: Ejner Bech Jensen, Hans-Henrik Kristensen Høgenhaug, Peter Kamp Hansen, Poul Erik Pedersen, Per Holse Mygind
  • Polypeptides having antimicrobial activity and polynucleotides encoding same
    Patent number: 7893196
    Abstract: The present invention relates to isolated polypeptides having antimicrobial activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: November 19, 2005
    Date of Patent: February 22, 2011
    Assignee: Novozymes Aderium Biotech A/S
    Inventors: Dorotea Raventos Segura, Per Holse Mygind, Mogens Trier Hansen, Marianne Vind Soerensen, Dorthe Sandvang
  • Antimicrobial peptides
    Patent number: 7829524
    Abstract: The present invention relates to polypeptides having antimicrobial activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: June 10, 2004
    Date of Patent: November 9, 2010
    Assignee: Novozymes Adenium Biotech A/S
    Inventors: Dorotea Raventos Segura, Per Holse Mygind, Hans-Henrik Kristensen Hoegenhaug, Alessandro Tossi